Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06910969 · ClinicalTrials.gov registry record · NA
Multidisciplinary Intervention for Adults With Chronic Graft-versus-host Disease
A NA study of Graft-Versus-Host Disease and Bone Marrow Transplant Complications, sponsored by Massachusetts General Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 350
- Enrollment target
- 2
- Study locations
NCT06910969 is a NA study of Graft-Versus-Host Disease and Bone Marrow Transplant Complications that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 350 participants, above the 73-participant average among 38 other Graft-Versus-Host Disease trials with a reported enrollment target (379% higher). The trial reports 2 study locations across 2 states.
The verdict
NCT06910969, a NA study of Graft-Versus-Host Disease and Bone Marrow Transplant Complications, is actively recruiting participants, sponsored by Massachusetts General Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 350 participants
- Enrollment target
- 2
- Study locations
Study Summary
The goal of this study is to demonstrate the efficacy of a multidisciplinary group-based telehealth intervention (HORIZONS) compared to minimally enhanced usual care for improving self-management and quality of life for hematopoietic stem cell transplant (HSCT) survivors living with chronic graft-versus host disease, and to identify critical facilitators and barriers for HORIZONS implementation and adoption.
Conditions Studied
Interventions
- BEHAVIORAL HORIZONS Intervention
- BEHAVIORAL Minimally enhanced usual care
Study Locations (2)
Florida
- University of Miami Sylvester Comprehensive Cancer Center - Miami
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 350 participants |
| Start Date | 2025-08-13 |
| Est. Completion | 2030-02-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06910969
The ClinicalTrials.gov registry entry for NCT06910969 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 350 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 73-participant average among 38 other Graft-Versus-Host Disease trials with a reported enrollment target (379% higher). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Graft-Versus-Host Disease appearing as the primary indexed condition, and to 2 interventions - of which HORIZONS Intervention is the first listed.
NCT06910969 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Florida, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06910969 about?
NCT06910969 is a clinical study titled "Multidisciplinary Intervention for Adults With Chronic Graft-versus-host Disease". The goal of this study is to demonstrate the efficacy of a multidisciplinary group-based telehealth intervention (HORIZONS) compared to minimally enhanced usual care for improving self-management and quality of life for hematopoietic stem cell transplant (HSCT) survivors living with chronic graft-ve...
What is the current status of trial NCT06910969?
This trial is currently recruiting. It is a NA study. The enrollment target is 350 participants. The study started on 2025-08-13. Estimated completion is 2030-02-01.
What conditions does trial NCT06910969 study?
This clinical trial studies the following conditions: Graft-Versus-Host Disease, Bone Marrow Transplant Complications.
What interventions are being tested in trial NCT06910969?
The interventions under investigation include: HORIZONS Intervention (BEHAVIORAL), Minimally enhanced usual care (BEHAVIORAL).
Who is sponsoring clinical trial NCT06910969?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06910969 being conducted?
This trial has 2 study locations across Florida, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Graft-Versus-Host Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Feasibility Study Using CLINIMACS® for Alpha/Beta T-Cell Depletion in Stem Cell Transplant
RECRUITING · NA
-
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
RECRUITING
-
A Study of Photobiomodulation (PBM) Therapy in People With Oral Graft-Versus-Host Disease (GVHD) After Stem Cell Transplant
RECRUITING · Phase 2
-
Parametric Response Mapping (PRM) for the Detection of Chronic Lung Injury in Hematopoietic Cell Transplant Recipients
RECRUITING
-
PTCY Plus uhCG/EGF for Graft Versus Host Disease Prophylaxis
RECRUITING · Phase 1
-
Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma
RECRUITING · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.